A pharmacokinetic study of diclofenac sodium in rats.

Biomed Rep

College of Animal Science, Yangtze University, Jingzhou, Hubei 434025, P.R. China.

Published: August 2017

AI Article Synopsis

  • The study investigated how diclofenac sodium (DIC) is processed in Sprague-Dawley rats after either an intravenous (i.v.) injection or oral administration (p.o.).
  • Blood samples were taken at various time intervals post-administration to analyze DIC concentration using liquid chromatography-mass spectrometry (LC-MS/MS).
  • Results indicated that DIC is quickly absorbed, distributed, and eliminated, with distinct pharmacokinetic profiles for both administration routes.

Article Abstract

The aim of the present study was to examine the pharmacokinetics of a single intravenous injection (i.v.) and oral administration (p.o.) of diclofenac sodium (DIC) in Sprague-Dawley (SD) rats. Twelve male SD rats were divided into 2 groups (n=6 per group); one group was injected intravenously with 2 mg/kg DIC, whereas the other group was lavaged with 2 mg/kg DIC. Blood samples were collected prior to DIC delivery (0 h) and 0.033, 0.083, 0.167, 0.25, 0.5, 1, 2, 4, 6, and 8 h post-administration. Blood plasma samples were analyzed using liquid chromatography-mass spectrometry (LC-MS/MS) following pretreatment to induce protein precipitation. Pharmacokinetics software was applied to calculate relevant pharmacokinetic parameters using a non-compartmental model. Following i.v. administration of DIC, the terminal elimination rate constant (λ), apparent terminal elimination half-life (t), area under the concentration-time curve from time 0 extrapolated to infinity (AUC0), clearance (CL), apparent volume of distribution (V), mean residence time (MRT), and apparent volume of distribution at steady state (V) were 0.57±0.05 l/h, 1.22±0.11 h, 3356±238 h × ng/ml, 0.60±0.04 l/h, 1.05±0.10 l, 1.05±0.07 h and 0.63±0.07 l, respectively. Following p.o. administration of DIC, the λ, t, C, t, AUC, CL, V, MRT were: 0.63±0.12 l/h, 1.12±0.18 h, 1272±112 ng/ml, 0.19±0.04 h, 2501±303 h × ng/ml, 0.81±0.10 l/h, 1.29±0.12 l, and 2.70±0.18 h, respectively. The pharmacokinetic parameters of i.v. and p.o. DIC in rats show that the drug is rapidly absorbed, distributed, and eliminated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526189PMC
http://dx.doi.org/10.3892/br.2017.942DOI Listing

Publication Analysis

Top Keywords

diclofenac sodium
8
mg/kg dic
8
pharmacokinetic parameters
8
administration dic
8
terminal elimination
8
apparent volume
8
volume distribution
8
dic
7
pharmacokinetic study
4
study diclofenac
4

Similar Publications

The presence of pharmaceuticals in aquatic ecosystems and their impact on humans and the environment are growing concerns in environmental health. This study aimed to evaluate the potential reproductive effects of diclofenac, ibuprofen, and aspirin on dissociated ovarian and testicular cells from Arabian Sea bream, Acanthopagrus arabicus. The cells were exposed to varying concentrations of the pharmaceuticals for 48 h.

View Article and Find Full Text PDF

Pharmaceuticals and per- and polyfluoroalkyl substances (PFAS) are persistent organic micropollutants (OMPs) posing environmental and health risks due to their bioaccumulative nature and potential toxicity. These OMPs spread to the environment due to the extensive use in today's society. Conventional wastewater treatment plants (WWTPs) are not designed to effectively remove these contaminants, making WWTPs an important pathway, especially for pharmaceuticals, to the aquatic environment.

View Article and Find Full Text PDF

The biotransformation of drugs by enzymes from the human microbiome can produce active or inactive products, impacting the bioactivity and function of these drugs inside the human host. However, understanding the biotransformation reactions of drug molecules catalyzed by bacterial enzymes in human microbiota is still limited. Hence, to characterize drug utilization capabilities across all the microbial phyla inside the human gut, we have used a knowledge-based approach to develop HgutMgene-Miner software which predicts xenobiotic metabolizing enzymes (XMEs) through genome mining.

View Article and Find Full Text PDF

: The proton-coupled amino acid transporter (PAT1) is an intestinal absorptive solute carrier responsible for the oral bioavailability of some GABA-mimetic drug substances such as vigabatrin and gaboxadol. In the present work, we investigate if non-steroidal anti-inflammatory drug substances (NSAIDs) interact with substrate transport via human (h)PAT1. : The transport of substrates via hPAT1 was investigated in Caco-2 cells using radiolabeled substrate uptake and in oocytes injected with , measuring induced currents using the two-electrode voltage clamp technique.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!